🟢 Edesa Biotech is trading 6.3% up in after-hours trading after pricing a $25 million public offering

Edesa Biotech is trading 6.30% up at $5.06 after pricing a $25 million underwritten public offering on August 20, 2026.

• The offering includes 3.87 million shares, pre-funded warrants, and accompanying warrants exercisable at $7.50.
• Expected net proceeds of approximately $23.1 million will fund general corporate purposes, including research, development, manufacturing, and working capital.
• The offering is expected to close on August 21, 2026.